Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.

Cancer Res. 1985 Sep;45(9 Suppl):4627s-4629s. Unique Identifier : AIDSLINE MED/85254488
Erfle V; Hehlmann R; Mellert W; Kruger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P; et al

Abstract: The prevalence of antibodies to human T-lymphotropic virus III was determined in acquired immunodeficiency syndrome (AIDS) risk groups by an enzyme linked immunosorbent assay and confirmatory tests in four different areas in West Germany. Twenty-four of 28 homosexual AIDS patients (86%), 24 of 33 homosexual patients with lymphadenopathy syndrome or AIDS related complex (73%), and 44 of 113 asymptomatic homosexuals at risk for AIDS (39%) were seropositive. In three groups of hemophiliacs, 8 of 35 in 1983 (23%), 25 of 65 in early 1984 (39%), and 19 of 23 in late 1984 (83%) showed positive results. Two sera from 36 polytransfused patients were also positive, whereas 36 selected blood donors, and 32 healthy laboratory and clinical personnel were all negative. Also no human T-lymphotropic virus III antibodies were detected in sera of 187 prostitutes in the Munich area.
Keywords: Acquired Immunodeficiency Syndrome/*ETIOLOGY/IMMUNOLOGY Antibodies, Viral/*ANALYSIS *Blood Transfusion Enzyme-Linked Immunosorbent Assay Female Germany, West Hemophilia/*IMMUNOLOGY *Homosexuality Human Male Personnel, Hospital Risk Sex Behavior Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDetiology/immunologyantibodies,viral/KWDanalysisKWDbloodtransfusionenzyme-linkedimmunosorbentassayfemalegermany,westhemophilia/KWDimmunologyKWDhomosexualityhumanmalepersonnel,hospitalrisksexbehaviorsupport,non-uKWDsKWDgov'tjournalarticle
851130
M85B0158

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .